Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | SGX523 |
| Synonyms | |
| Therapy Description |
SGX523 is a highly selective, ATP-competitive inhibitor of MET that blocks Met signaling, resulting in cell death in tumor cells (PMID: 19934279). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| SGX523 | SGX-523 | MET Inhibitor 59 | SGX523 is a highly selective, ATP-competitive inhibitor of MET that blocks Met signaling, resulting in cell death in tumor cells (PMID: 19934279). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|